ImmunityBio
IBRX
£1.90
Share price
-4.15%
Change (1 day)
-55.04%
Change (1 year)
Categories
ImmunityBio (IBRX) - Cash on Hand
Cash on Hand as of March 2025 : £46.11 Million
According to ImmunityBio's latest financial reports the company has £46.11 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ImmunityBio - Cash on Hand chart (from 2020 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | £0.11 B | -42.92% |
| 2023-12-31 | £0.20 B | 136.07% |
| 2022-12-31 | £88.59 M | -62.29% |
| 2021-12-31 | £0.23 B | 233.35% |
| 2020-12-31 | £70.47 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | £0.15 B | 230.77% | 🇺🇸 USA |